RS

Ranjeet Singh

Active Director Whole-Time Director DIN 11753902
DIN 11753902 First appointment Jun 2026 Primary industry Chemicals and Materials
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Ranjeet Singh

Ranjeet Singh is a Whole-Time Director at Shiva Pharmachem Limited (since 2026). The company operates in Chemicals and Materials.

DIN 11753902
Primary Designation Whole-Time Director
Industry Chemicals and Materials
First Appointment 26 Jun 2026
Oldest Company Age 27 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shiva Pharmachem Limited U24231GJ1999PLC035615
Whole-Time Director26 Jun 20261999Active

Directorship timeline

Open interactive timeline →
Shiva Pharmachem Limited
Premium access

Shareholding and investment profile for Ranjeet Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ranjeet Singh

Ranjeet Singh currently holds 1 directorship: Shiva Pharmachem Limited (Whole-Time Director, since 26 Jun 2026).

Ranjeet Singh was first appointed on 26 Jun 2026 as Whole-Time Director at Shiva Pharmachem Limited.

The current boards of Ranjeet Singh's companies include Dukhabandhu Rath (Shiva Pharmachem Limited), Himali Harnish Patel (Shiva Pharmachem Limited), Madhavi Vishal Agrawal (Shiva Pharmachem Limited), Milin Kaimas Mehta (Shiva Pharmachem Limited), Rahul Rakesh Agrawal (Shiva Pharmachem Limited), Rakesh Shiwebhagwan Agrawal (Shiva Pharmachem Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available